Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Semin Oncol. 2015 Jul 10;42(5):748–763. doi: 10.1053/j.seminoncol.2015.07.006

Table 3.

Biospecimens and Data Collected from Large-Scale Prevention Trials

PCPT SELECT BCPT STAR
BASELINE SAMPLES (PRE-THERAPY)
Serum X X X
Plasma X
White Blood Cells X X X X
Red Blood Cells X
Toenail Clippings X
SERIAL SAMPLE COLLECTIONS DURING TRIAL (DURING AND POST-THERAPY)
Blood (as above) Annual Year 5 (all) 6 months, Year 1, 2, 4, 6, 8 (subset)
TUMOR TISSUE COLLECTED
Invasive Target Cancers X X X X
All Other Invasive Cancers X X
DATA COLLECTION
Sociodemographic X X X X
Family Cancer History Prostate Prostate, lung, colon Breast Breast
Medical History, including height, weight, cardiovascular health, prior cancers. X Plus detailed anthropomorphic data X X Plus hysterectomy and menopausal status X Plus hysterectomy status
Medications Limited Extensive Limited Limited
Diet At year 1 At baseline At baseline and updated
Supplement Use X X Calcium supplements only Calcium supplements only
Smoking Baseline only Baseline and updated Baseline and updated Baseline only
Quality of Life X On subset only On subset only On subset only
OTHER PROCEDURES
Screening Procedures Annual PSA and DRE Prostate screening per local site guidelines Annual Mammography
Endometrial biopsy on subset
Annual Mammography